Sponsored Links
Unigene Laboratories Inc
News and Blogs

Total : 144 View more »
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty
www.bioportfolio.co.uk | Nov 18, 2008
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty (Business Wire)
biz.yahoo.com | Nov 14, 2008
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty. - FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the
WuXi PharmaTech (Cayman) Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha)
seekingalpha.com | Sep 23, 2008
Good day everyone and welcome to WuXi PharmaTech’s second quarter 2008 results conference call. This call is being recorded. For opening remarks, I would now like to turn the conference over to Dr. Hai Mi, Vice President of Corporate Communications. Dr. Mi, please go ahead, sir. Hai Mi
Unigene
www.pharmaceutical-technology.com | May 7, 2008
Unigene is a biopharmaceutical company that delivers oral and nasal delivered peptide drugs including salmon calcitonin, oral PTH analogs, oral leuprolide and oral desmopressin.
http://www.pharmaceutical-technology.com/contractors/drug_delivery/unigene
Web Sites

Total : 79 View more »
UGNE: Begins Ph I Trial of Oral PTH for Osteoporosis - Zibb.com
www.zibb.com
By Fain Hughes, fhughes@knobias.com Unigene Laboratories, Inc. (UGNE) has initiated a Phase I clinical study in the U.S. with its proprietary formulation of oral PTH for the treatment of osteoporosis. Twenty-four healthy postmenopausal women have been enrolled in the study, which is designed to
http://www.zibb.com/article/4105131/UGNE+Begins+Ph+I+Trial+of+Oral+PTH+for+Osteoporosis
Biopharmaceutical Products in the U.S. and European Markets - Recent Approvals
Influenza Vaccine/CSL [Influenza Virus Vaccine, Trivalent, Types A and B - AFLURIA; Fluvax; Enzira ] - granted on 9/28/07 to CSL Ltd. for prophylaxis against smallpox (in the biodefense stockpile).
ASSOC DIR OF CAPITAL PROJECTS THOUSAND OAKS CA AMGEN INC. ASSOC MGR, PROCESS ENGINEERING SEATTLE WA...
www.interphex.com
ASSOC DIR OF CAPITAL PROJECTS THOUSAND OAKS CA AMGEN INC. ASSOC MGR, PROCESS ENGINEERING SEATTLE WA ASTELLAS PHARMA TECHNOLOGIES, EXECUTIVE V.P, SITE OPERATIONS NORMAN OK ASTELLAS PHARMA TECHNOLOGIES, V.P.
http://www.interphex.com/images/100026/2006images/ListforWeb.pdf
Q3 2008 Bowne & Co Earnings Release - After Market Close (CCBN)
biz.yahoo.com
Learn when companies announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by adding it to your calendar.
News from Zibb.com
Total : 16 View more »
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent
NEW YORK, Nov 17, 2008 /PRNewswire-FirstCall via COMTEX/ --
Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.
The show is designed to provide viewers with insight into a company's latest news, and its impact on the company's growth.
Shows air Monday through Friday at:
http://tv.wallst.net/3-min-press/3-min-press.php
The following executives were interviewed on today's show:
1. Tony Spier, CEO of Wells-Gardner Electronics Corporation (Amex: WGA).
To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Anthony-Spier/342/1352/
Ask Tony Spier a question, post a comment on his profile page, and
join his financial social network today at:
http://my.wallst.net/Anthony-Spier
2. Laurie Latham, CFO and Senior VP of Finance and Administration for
ViewCast.com, Inc. (OTC Bulletin Board: VCST). To view this clip in
its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Laurie-Latham/342/1353/
Ask Laurie Latham a question, post a comment on her profile page, and
join her financial social network today at:
http://my.wallst.net/Laurie-Latham
3. Steve Eversole, CEO of Kentucky USA Energy, Inc.
(OTC Bulletin Board: KYUS). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Steven-Eversole/342/1350/
Ask Steve Eversole a question, post a comment on his profile page, and
join his financial social network today at:
http://my.wallst.net/Steven-Eversole
4. Warren Levy, President and CEO for Unigene Laboratories, Inc.
(OTC Bulletin Board: UGNE). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Warren-Levy/342/1357/
Ask Warren Levy a question, post a comment on his profile page, and
join his financial social network today at:
http://my.wallst.net/Warren-Levy
5. Kenneth Aldrich, CEO of International Stem Cell Corporation
(OTC Bulletin Board: ISCO). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Kenneth-Aldrich/342/1351/
Ask Kenneth Aldrich a question, post a comment on his profile page,
and join his financial social network today at:
http://my.wallst.net/Kenneth-Aldrich
6. Michael Ansley, President and CEO for Diversified Restaurants Holding,
Inc. (OTC Bulletin Board: DFRH). To view this clip in its entirety,
visit:
http://www.tv.wallst.net/r/3-minute-press/Michael-Ansley/342/1356/
Ask Michael Ansley a question, post a comment on his profile page, and
join his financial social network today at:
http://my.wallst.net/Michael-Ansley
7. Colin Hendrick, President and CEO of SmartMetric, Inc.
(OTC Bulletin Board: SMME). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Colin-Hendrick/342/1358/
Ask Colin Hendrick a question, post a comment on his profile page, and
join his financial social network today at:
http://my.wallst.net/Colin-Hendrick
8. John Maier, CEO of we-R-you Corporation (Pink Sheets: WERU). To view
this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/John-Maier/342/1354/
Ask John Maier a question, post a comment on his profile page, and
join his financial social network today at:
http://my.wallst.net/John-Maier
About WallStreet Direct, Inc.
WallStreet Direct, Inc. operates Wall St. Network (http://www.wallst.net), a leading source of up-to-the-minute business news, social networking applications, comprehensive financial tools and original multimedia content for the investment community. In addition to WSN, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. We received two hundred eighty dollars from ViewCast.com, Inc. in 2006 for press release dissemination services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.
Contact:
WallStreet Direct, Inc.
800-4-WALLST
SOURCE WallStreet Direct, Inc.; Wells-Gardner Electronics Corporation;
ViewCast.com, Inc.; Kentucky USA Energy, Inc.; Unigene Laboratories,
Inc.; International Stem Cell Corporation; Diversified Restaurants
Holding, Inc.; SmartMetric, Inc.; we-R-you Corporation
http://www.wallst.net
Tags: advertising amex business ceo community electronics energy executive finance kentucky multimedia networking online otc president restaurants video
Companies: Diversified Restaurant Holdings Inc (DFRH), International Stem Cell Corp (ISCO), Kentucky USA Energy Inc (KYUS), SmartMetric Inc (SMME), Unigene Laboratories, Inc. (UGNE), ViewCast.com, Inc. (VCST), We-R-You Corp (WERU), Wells-Gardner Electronics Corp. (WGA)
[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent
NEW YORK, Nov 13, 2008 /PRNewswire-FirstCall via COMTEX/ --
Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.
The show is designed to provide viewers with insight into a company's latest news, and its impact on the company's growth.
Shows air Monday through Friday at:
http://tv.wallst.net/3-min-press/3-min-press.php
The following executives were interviewed on today's show:
1. Thaddeus Dupper, President and CEO for Evolving Systems, Inc. (Nasdaq: EVOL). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Thaddeus-Dupper/338/1333/
Ask Thaddeus Dupper a question, post a comment on his profile page, and join his financial social network today at:
http://my.wallst.net/Thaddeus-Dupper
2. Nancy Koenig, President for Merge Healthcare Inc. (Nasdaq: MRGE). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Nancy-Koenig/338/1331/
Ask Nancy Koenig a question, post a comment on her profile page, and join her financial social network today at: http://my.wallst.net/Nancy-Koenig
3. John Wilmers, President and CEO for Ballantyne of Omaha, Inc. (Amex: BTN). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/John-Wilmers/338/1332/
Ask John Wilmers a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/John-Wilmers
4. John Whitney, President for Itronics, Inc. (OTC Bulletin Board: ITRO). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/John-Whitney/338/1325/
Ask John Whitney a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/John-Whitney
5. Dr. Ronald Levy, Executive Vice President for Unigene Laboratories, Inc. (OTC Bulletin Board: UGNE). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Ronald-Levy/338/1326/
Ask Dr. Ronald Levy a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Ronald-Levy
6. Roger Dudley, CEO for Fonix Corp. (OTC Bulletin Board: FNIX). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Roger-Dudley/338/1328/
Ask Roger Dudley a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Roger-Dudley
7. Douglas Pritt, President and CEO for NavStar Technologies, Inc. (Pink Sheets: NVSR). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Douglas-Pritt/338/1334/
Ask Douglas Pritt a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Douglas-Pritt
8. Adam F. Coblin, Chairman and CEO for UDS Group, Inc. (Pink Sheets: UDSG). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Adam-Coblin/338/1330/
Ask Adam F. Coblin a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Adam-Coblin
9. Robert Oswald, President for HearAtLast Holdings, Inc. (Pink Sheets: HRAL). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Robert-Oswald/338/1327/
Ask Robert Oswald a question, post a comment on his profile page, and join his financial social network today at: http://my.wallst.net/Robert-Oswald
10. Douglas Pulver, Senior Managing Director for Bionic Products, Inc. (Pink Sheets: BNPD). To view this clip in its entirety, visit:
http://www.tv.wallst.net/r/3-minute-press/Douglas-Pulver/338/1329/
Ask Douglas Pulver a question, post a comment on his profile page, and join his financial social network today at:
http://my.wallst.net/Douglas-Pulver
About WallStreet Direct, Inc.
WallStreet Direct, Inc. operates Wall St. Network (http://www.wallst.net), a leading source of up-to-the-minute business news, social networking applications, comprehensive financial tools and original multimedia content for the investment community. In addition to WSN, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net), a hub for business and finance video content. We received fifteen million restricted shares of ITRO from Itronics, Inc. in 2006 for media and advertising services (all shares sold). We received six thousand seven hundred fifty dollars from UDS Group, Inc. in 2006, and an additional eleven thousand seven hundred dollars in 2007, for media and advertising services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/LATU121LOGO)
Contact:
WallStreet Direct, Inc.
800-4-WALLST
SOURCE WallStreet Direct, Inc.; Evolving Systems, Inc.; Merge Healthcare Incorporated; Ballantyne of Omaha, Inc.; Itronics, Inc.; Unigene Laboratories, Inc.; Fonix Corporation; NavStar Technologies, Inc.; UDS Group, Inc.; HearAtLast Holdings, Inc.; Bionic Products, Inc.
http://www.wallst.net
Tags: advertising amex business ceo community executive finance healthcare media multimedia nasdaq networking online otc president products technology video
Companies: Ballantyne of Omaha, Inc. (BTN), Bionic Products Inc (BNPD), Evolving Systems, Inc. (EVOL), Fonix Corp. (FNIX), Hear AtLast Holdings Inc (HRAL), Itronics Inc. (ITRO), Merge Technologies, Inc. (MRGE), NavStar Technologies Inc (NVSR), UDS Group Inc (UDSG), Unigene Laboratories, Inc. (UGNE)
Fitness & Health V, Wellness Feature Releases - Zibb.com
SAN FRANCISCO, Nov 13, 2008 (BUSINESS WIRE) --
The following releases focus on the topic Fitness & Health V, Wellness:
ALL TIME-OFFS ARE IN EASTERN TIME, UNLESS NOTED STORIES MOVED AT 4:35 AM ET ON NOVEMBER 13, 2008.
New Progress on Treatment to Keep You Safe Following Surgery Source: Cortex Pharmaceuticals
Osteoporosis Drugs May Prevent Future Bone Growth Source: Unigene Laboratories, Inc.
TAMPA, Fla.-- AthleteInMe.com Promotes Wellness Online To Reduce Healthcare Costs Source: AthleteInMe.com
CHATSWORTH, Calif.--Natrol Supplements Help Consumers De-Stress, Digest, And Rest During the Hectic Holidays Source: Natrol, Inc.
Of Mice and Men: Award-Winning Oncologist Leads New Advancement in Personalized Medicine Source: Champions Biotechnology
SANTA ANA, Calif.--Survey Reveals Lack of Education by Healthcare Professionals May Be Barrier to Consumers Recognizing Health Benefits of Soy Source: Stremicks Heritage Foods
BRADENTON, Fla.--Gevity Partners With Olympic Athlete to Promote a Healthier Workforce and Reduce Healthcare Costs for Business Owners Source: Gevity
Stem Cells, Reborn Source: International Stem Cell Corporation
The following knowledgeable industry leaders and scholars from Business Wire's ExpertSource database are available to discuss topics relating to Fitness & Health V, Wellness:
Dr. Kirschenbaum is Clinical Director and Chief Program Officer of Wellspring. He is a licensed clinical psychologist in Illinois and California, Professor of Psychiatry & Behavioral Sciences at Northwestern University Medical School, Fellow and Diplomate in Clinical Health Psychology of the American Psychological Association and former president of its Division of Exercise and Sport Psychology. He has served as a consultant to the United States Olympic Committee, the National Basketball Association, the Ladies Professional Golf Association, the Chicago Bears, numerous professional journals, and several major corporations. Dr. Kirschenbaum has provided addresses at many professional conferences worldwide, received numerous grants for research, and published 9 books and 125 journal articles on weight loss, sport psychology, and related topics.
PR Contact: Meredith Schneider
Telephone: (919) 277-1165
mschneider@fwv-us.com
Kathleen Buchanan is CEO of iinnLight Technologies, Inc. and has over 20 years of management experience in the retail sector. She founded iinnLight in 2006 to fulfill her passionate desire to bring the energizing and rejuvenating benefits of light therapy to people proactively pursuing beauty, wellness and vitality. Kathleen has a proven track record for identifying business opportunities and driving revenue growth. Prior to forming iinnLight, she provided management expertise for some of the country's top retail companies. While serving as Senior Vice President for Bloomingdales, she profitably developed a $200 million business for the corporation, distinguishing herself as a key negotiator. Kathleen holds a B.S. Degree in Business from California State Polytechnic University.
PR Contact: Gina Ray
Telephone: 949-370-0941
gray@thepowermarkgroup.com
Registered journalists can submit queries to the ExpertSource staff and/or search for more experts in this and various other topics by going to www.businesswire.com and logging in with your email address and PressPass password. If you are not registered, you may do so at www.businesswire.com. For more information or assistance with ExpertSource, please contact Stacey Frank, ExpertSource Coordinator/Business Wire at 312/223-1037, stacey.frank@businesswire.com.
The following are upcoming Features Package release dates:
November 17 - Food & Beverage III November 18 - Travel
Questions? Contact Business Wire's Media Relations team at media.relations@businesswire.com or features@businesswire.com.
SOURCE: Business Wire
Business Wire Media Relations Team media.relations@businesswire.com or Business Wire, Washington Angela Mendola, 703-243-0400
Tags: basketball biotechnology business california ceo clinical consultant drugs education email exercise fitness florida food golf grants health healthcare illinois media medical medicine men olympics online osteoporosis pharmaceuticals president psychology research retail revenue surgery technology track travel university
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty - Zibb.com
FAIRFIELD, N.J., Nov 14, 2008 (BUSINESS WIRE) --
Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the Scrip World Pharmaceutical News "Company League Tables" ranking of the top fifty biotechnology companies in the world ranked by 2007 sales of pharmaceutical products. In the October 31, 2008, edition of the publication, Unigene ranked number thirty-three in the listing, with $12.76 million in sales, representing an increase of over 350% from 2006. Unigene ranked 18th among US-based companies. The executive briefing also singled out Unigene as one of a handful of companies that "reported significantly increased sales for 2007 compared with the previous year."
"We are delighted to be recognized in this fashion by so authoritative a publication as Scrip World Pharmaceutical News," said Dr. Warren Levy, President and CEO of Unigene. "Fortical has now captured more than 59% of U.S. nasal calcitonin prescriptions, further solidifying its position as the most frequently prescribed nasal calcitonin product in the U.S. We continue to be optimistic about the future prospects for Fortical, as well as improved formulations of calcitonin."
About Scrip World Pharmaceutical News
Established in 1976, Scrip World Pharmaceutical News is the leading source of global news in the pharmaceutical industry. Delivering an unrivalled range of pharma market intelligence, Scrip's network of experienced, locally based journalists provide you with a truly international and independent perspective. Scrip World Pharmaceutical News keeps readers abreast of licensing activity, distribution and trade agreements, the actions of companies and associations, and of the policies and practices of governments and their agencies. From drug manufacturers to CROs, biotech companies to regulators, Scrip subscribers know the value of the unbiased, independent pharmaceutical business intelligence that only Scrip provides. For more information, please visit www.scripnews.com.
About Unigene Laboratories, Inc.
Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies. Fortical(R), Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005. Unigene has licensed the U.S. rights for Fortical(R) to Upsher-Smith Laboratories, worldwide rights for its oral PTH technology to GlaxoSmithKline and worldwide rights for its calcitonin manufacturing technology to Novartis. Unigene's patented oral delivery technology has successfully delivered, in preclinical and/or clinical trials, various peptides including calcitonin, PTH and insulin. Unigene's patented manufacturing technology is designed to cost-effectively produce peptides in quantities sufficient to support their worldwide commercialization as oral or nasal therapeutics. For more information about Unigene, call (973) 882-0860 or visit www.unigene.com. For information about Fortical, visit www.fortical.com.
Safe Harbor Statement
Safe Harbor statements under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based upon Unigene Laboratories, Inc.'s management's current expectations, estimates, beliefs, assumptions, and projections about Unigene's business and industry. Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "potential," "continue," and variations of these words (or negatives of these words) or similar expressions, are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These risks and uncertainties include the risks associated with the effect of changing economic conditions, trends in the products markets, variations in Unigene's cash flow, market acceptance risks, technical development risks and other risk factors detailed in Unigene's Securities and Exchange Commission filings.
SOURCE: Unigene Laboratories, Inc.
Unigene Investors: The Investor Relations Group Erika Moran/Dian Griesel, PhD 212-825-3210 or Media: Janet Vasquez, 212-825-3210
Tags: biotechnology business business intelligence ceo clinical drugs fashion fda manufacturing market osteoporosis pharmaceuticals president products sales securities technology trade
Companies: Unigene Laboratories, Inc. (UGNE)
News from Zibb.com
- [video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent
- [video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent
- Fitness & Health V, Wellness Feature Releases - Zibb.com
- Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty - Zibb.com
Explore Related Products
- Marketing Services
- Drug Development
- Healthcare Devices
- Motor Vehicle Components
- Vitamin D
- Monoclonal Antibodies
- Cyanocobalamin
- Drug Delivery Devices
- Specification Bags
- Chemical Synthesis
- Dairy Products
- Direct Marketing
Explore in Related Industries
- Unigene Laboratories Inc in:
- Healthcare & Medicine (140)
- Chemicals, Plastics & Rubber (24)
- Finance & Tax (17)
- General Business (16)
- Agriculture & Horticulture (15)
Explore Related Topics
- Health
- Medical Science
- Pharmaceutical Science
- Accounting & Finance
- Drug Addiction & Habituation
- CEO
- Stocks & Stock Market
- Medical, Pharmaceuticals & Biotechnology
- Telecommunications Industry
- Energy Industry
- Finance & Insurance
- Patents & Trademarks
